Skip to main content
OpenTrials
Completed

NCT Number: NCT03007290

Clinical Usefulness of Therapeutic Drug Monitoring of Colistin in Patients Treated With Colistin.

Clinical usefulness of therapeutic drug monitoring of colistin in patients treated with colistin

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Multidrug-resistant Gram-negative Bacteria Infection

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Seoul National University Bundang Hospital

Seongnam, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age over 18 years old.
  • Those who receive colistin therapy for the treatment of multi-drug resistant gram negative bacteria infection.

Exclusion criteria

  • Those who received colistin therapy less than 48 hours
  • Those who received colistin therapy through the bronchus

Treatment and study plan

therapeutic drug monitoring

Other

Therapeutic drug monitoring for colistin

Primary outcomes

  1. AKI

    Time frame: Through study completion, an average of 1 month

    Emergence rate of acute kidney injury

Secondary outcomes

  1. Death

    Time frame: Through study completion, an average of 1 month

    Death rate

  2. Negative conversion rate

    Time frame: Through study completion, an average of 1 month

    Culture-negative conversion rate Treatment success Treatment success

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Jan 2, 2017
Registry last updated
Apr 18, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.